13 employees
Innodal develops and produces antimicrobials for various sectors and offers innovative solutions to inhibit microbiological pathogens.
2017
$944K
from 1 investors over 1 rounds
Laboratoire Innodal raised $944K on May 31, 2022
Investors: Canadian Food Innovation Network